Exagen inc. announces $26.2 million debt refinancing

Exagen inc. announced that it entered into an amendment to its loan and security agreement with its primary lender, an affiliate of innovatus capital partners, llc (“innovatus”). the amended agreement provides a $26.2 million, 5-year term loan at 8.5% interest, of which 2.0% is paid in-kind in the form of additional term loans. additional information regarding the amendment is available in the company’s current report on form 8-k filed with the securities and exchange commission on november 21, 2019.
XGN Ratings Summary
XGN Quant Ranking